Cargando…
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency
Autores principales: | Kälkner, Karl Mikael, Sundström, Anders, Nurminen, Marja-Leena, Larsson, Maria, Ljung, Rickard, Arthurson, Veronica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926420/ https://www.ncbi.nlm.nih.gov/pubmed/36786959 http://dx.doi.org/10.1007/s40264-023-01275-7 |
Ejemplares similares
-
Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccines
por: Gedeborg, Rolf, et al.
Publicado: (2023) -
Association between SARS-CoV-2 vaccination and healthcare contacts for menstrual disturbance and bleeding in women before and after menopause: nationwide, register based cohort study
por: Ljung, Rickard, et al.
Publicado: (2023) -
Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Ljung, Rickard, et al.
Publicado: (2022) -
The profile of the COvid-19 VACcination register SAFEty study in Sweden (CoVacSafe-SE)
por: Ljung, Rickard, et al.
Publicado: (2021) -
The Swedish dental health register - validation study of remaining and intact teeth
por: Ljung, Rickard, et al.
Publicado: (2019)